Lucid Diagnostics (LUCD) Research & Development (2022 - 2025)
Historic Research & Development for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $1.3 million.
- Lucid Diagnostics' Research & Development fell 2364.95% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 1624.59%. This contributed to the annual value of $6.0 million for FY2024, which is 1737.45% down from last year.
- Lucid Diagnostics' Research & Development amounted to $1.3 million in Q3 2025, which was down 2364.95% from $1.3 million recorded in Q2 2025.
- Lucid Diagnostics' 5-year Research & Development high stood at $3.4 million for Q2 2022, and its period low was $1.3 million during Q2 2025.
- In the last 4 years, Lucid Diagnostics' Research & Development had a median value of $1.7 million in 2024 and averaged $1.9 million.
- Per our database at Business Quant, Lucid Diagnostics' Research & Development plummeted by 4688.95% in 2023 and then skyrocketed by 315.79% in 2024.
- Lucid Diagnostics' Research & Development (Quarter) stood at $2.4 million in 2022, then decreased by 21.46% to $1.9 million in 2023, then decreased by 24.24% to $1.5 million in 2024, then decreased by 12.46% to $1.3 million in 2025.
- Its Research & Development stands at $1.3 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.4 million for Q1 2025.